Proposing a framework to quantify the potential impact of pharmacokinetic drug–drug interactions caused by a new drug candidate by using real world data about the target patient population

Documenti analoghi

• Evaluation of potential drug–drug interactions with medical cannabis
  di: Jessie Jia Yi Ho, et al.
  Pubblicazione: (2024)
• Computational repurposing of oncology drugs through off‐target drug binding interactions from pharmacological databases
  di: Imogen R. Walpole, et al.
  Pubblicazione: (2024)
• The impact of repeated drug desensitisation on quality of life in drug hypersensitivity
  di: Begum Gorgulu Akin, et al.
  Pubblicazione: (2025)
• Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure
  di: Nikhil Pillai, et al.
  Pubblicazione: (2024)
• A phase I drug–drug interaction study to assess the effect of futibatinib on P‐gp and BCRP substrates and of P‐gp inhibition on the pharmacokinetics of futibatinib
  di: Amanda Long, et al.
  Pubblicazione: (2024)